Target Stake Control
Target Ownership Stake
22.0%
Scenarios
Market Parameters
Current Exor Stake
15.0%
Philips Market Cap (€ Bn)
24.50
Shares Outstanding (M)
Capital Required
€1,715M
+7.0% incremental stake
Additional Shares
To be acquired
Total Held Valuation
€5,390M
At current Market Cap
Accounting Method
Active (Equity Method)
IAS 28 / ASC 323 Triggered
Ownership Distribution
Governance Milestones
15.0% - Initial Anchor Investment
Baseline minority stake establishing strategic partnership in HealthTech.
20.0% - IAS 28 Equity Accounting Threshold
Grants Significant Influence. Exor can equity-account Philips net earnings.
22.0% - Agreement Ceiling Cap
Maximum allowable stake under the updated bilateral governance framework.
Deployment & Governance Summary
| Metric | Value | Description |
|---|---|---|
| Target Stake Percentage | 22.0% | Simulated total ownership level |
| Incremental Stake Acquired | 7.0% | Additional ownership beyond initial 15.0% base |
| Additional Shares Needed | 64.75 M | Total number of shares to acquire on open market / block deal |
| Capital Outlay Required | €1,715.00 M | Total investment required based on current market valuation |
| Total Held Stake Value | €5,390.00 M | Fair market value of Exor's combined holding |
| Effective Voting Rights | 22.0% | Direct voting strength in Philips corporate governance |
| Accounting Status | Active (Exceeds 20% significant influence threshold) | Financial reporting classification for Exor balance sheet |